Loic Vaillant Selected Research

Melkersson-Rosenthal Syndrome

1/2022	Response to systemic therapies in granulomatous cheilitis: Retrospective multicenter series of 61 patients.
12/2019	Efficacy of vedolizumab in granulomatous cheilitis refractory to TNFα inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Loic Vaillant Research Topics

Disease

2	Melkersson-Rosenthal Syndrome 01/2022 - 12/2019
1	Body Weight (Weight, Body) 01/2002
1	Bullous Pemphigoid (Pemphigoid) 01/2002

Drug/Important Bio-Agent (IBA)

1	vedolizumabIBA 12/2019
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 01/2002
1	Prednisone (Sone)FDA LinkGeneric 01/2002
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2002

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2002